Top Analyst Upgrades and Downgrades: Allergan, Amazon, Chipotle, Netflix, QIWI, Sarepta and More

Print Email

Diamondback Energy Inc. (NASDAQ: FANG) was raised to Buy from Neutral with a $101 price target (versus a $87.99 close) at Roth Capital.

Digital Realty Trust Inc. (NYSE: DLR) was raised to Buy from Hold at Deutsche Bank and the price target was raised to $68 from $56 (versus a $61.23 close). Its yield is still 5.7% despite almost a 50% rise from its 52-week low.

Five Below Inc. (NASDAQ: FIVE) was raised to Outperform from Market Perform and given a $41 to $42 value (versus a $34.40 close) at Wells Fargo.

Halliburton Co. (NYSE: HAL) was reiterated as Buy and the price target was raised to $84 from $79 at Argus.

Huntington Bancshares Inc. (NASDAQ: HBAN) was raised to Outperform with a $11.50 price target (versus a $9.74 close) at Keefe Bruyette & Woods.

ALSO READ: GE’s Value and Identity Crisis for 2014 and 2015

Netflix Inc. (NASDAQ: NFLX) was mixed after earnings, but we have seen some analyst price targets lifted: RBC raised to $530 from $500 and FBR raised to $440 from $390. Sterne Agee maintained a Neutral but lowered estimates. Credit Suisse maintained a Neutral but raised its target to $430 from $369.

QIWI PLC (NASDAQ: QIWI) has been smacked due to its online payment system exposure in Russia, but the company was started as Positive with a price target of $50 (versus a $37.58 close) at Susquehanna.

Realogy Holdings Corp. (NYSE: RLGY) was raised to Buy from Neutral at Citigroup.

Sanmina Corp. (NASDAQ: SANM) was raised to Hold from Sell at Deutsche Bank.

Sarepta Therapeutics Inc. (NASDAQ: SRPT) was started as Neutral at Merrill Lynch, but the firm issued a $27 price objective (versus a $21.57 close) and it also said that it has significant potential but is very risky.

SunTrust Banks Inc. (NYSE: STI) downgraded to Equal Weight from Overweight at Evercore.

Valspar Corp. (NYSE: VAL) was raised to the prized Conviction Buy List at Goldman Sachs, but the hike was up all the way from Neutral. The price target was raised to $97 from $83, versus a $76.18 close.

ALSO READ: How Analysts and Investors Value Apple Ahead of Earnings

In case you missed Monday’s top analyst upgrades and downgrades, they included Apple, ARM Holdings, DaVita Healthcare, GE, GoPro, Itron, Regeneron Pharmaceuticals and many more.